Retrospective blood test study shows high breast cancer discrimination
A retrospective feasibility study found that serum BF-09 levels distinguished breast cancer from controls with 93.2% sensitivity and 85% specificity ...
A retrospective feasibility study found that serum BF-09 levels distinguished breast cancer from controls with 93.2% sensitivity and 85% specificity ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.